More information about text formats
The use of high dose melatonin early and aggressively for those infected with COVID-19 was the subject of an international symposium held in December 2020 (1). Dr Richard Neel reported on over 1000 cases that have responded to monotherapy with melatonin.
Why this works, as speculated upon in this article, is open to debate. What is most important is that people can benefit from this treatment modality. Thank you for the opportunity to raise awareness of this underappreciated therapeutic option.